Target : Cross-over pharmacogenetictrial on the response of different loading doses of clopidogrel depending on the presence of variant CYP2C19*2

Trial date : 2009

Number of patients : 109

Source of funding : Public (PHRC)

Centers participating : Monocenter (Pitié-Salpêtrière)

N°NCT : NCT00822666

STATUS

Publication in JACC Cardiov. Interv. – apr 2011